Home > Financial Ratios > STRIDES PHARMA SCIENCE

STRIDES PHARMA SCIENCE
EV/Core EBITDA

    Back to All Ratios
STRIDES PHARMA SCIENCE is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for STRIDES PHARMA SCIENCE
Please provide your vote to see the results

STRIDES PHARMA SCIENCE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 12.039.6951.0913.848.11

What is the latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE ?

The latest EV/Core EBITDA ratio of STRIDES PHARMA SCIENCE is 12.03 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202412.03
Mar20239.69
Mar202251.09
Mar202113.84
Mar20208.11

How is EV/Core EBITDA of STRIDES PHARMA SCIENCE Trending?

Years EV/Core EBITDA % Change
Mar2024 12.03
24.15
Mar2023 9.69
-81.03
Mar2022 51.09
269.15
Mar2021 13.84
70.65
Mar2020 8.11 -

Other Financial Ratios of STRIDES PHARMA SCIENCE


Compare EV/Core EBITDA ratio of peers of STRIDES PHARMA SCIENCE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE ₹6,016.5 Cr -2.1% -5.9% -24.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,032.0 Cr 0.9% 2.2% 23.9% Stock Analytics
DIVIS LABORATORIES ₹162,252.0 Cr 3.3% 4.7% 58% Stock Analytics
CIPLA ₹124,457.0 Cr 0.5% 2% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,425.0 Cr -0.4% 2.8% 24.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,152.8 Cr -0.8% -0.4% 0.8% Stock Analytics


STRIDES PHARMA SCIENCE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
STRIDES PHARMA SCIENCE

-2.1%

-5.9%

-24.8%

SENSEX

0.9%

3%

8.9%


You may also like the below Video Courses